Share

Cancer Medicines Forum workshop

Amsterdam, NL (Hybrid Event)

The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.

The CMF will report its observations and preliminary solutions to address treatment optimisation at a hybrid workshop at the EMA under the Auspices of the EU Belgian Presidency.

Date: Friday, 5 April 2024, 1:00-6:00 PM (CEST)
Location: European Medicines Agency, Amsterdam

Registration will close on 1 March 2024 for in-person participation and will remain open until 29 March 2024 for online participation.

Next events

  • EORTC Brain Tumour Group Spring Meeting

    EORTC HQ, Brussels, Belgium

  • EORTC Melanoma Group Spring Meeting 2025

    Frankfurt, Germany

  • EORTC Lymphoma Group Spring Meeting 2025

    Copenhagen, Denmark

  • ECHNO 2025

    Amsterdam, Netherlands

  • EORTC Quality of Life Group Spring Meeting 2025

    Rotterdam, Netherlands